The FDA has approved the first mRNA flu shot: Moderna’s mFlusiva – but immunologist Dr. Jessica Rose says it safety tests are flawed.
“… You will find the safety data that definitively shows that more people died in the context of the mRNA-1010 injectable product than in the comparator group,” writes Dr. Rose.
“You should know that the comparator group ALSO were given a flu vaccine – NOT A SALINE PLACEBO.”
Reuters reports the approval covers adults 50 and older, based on a late-stage trial of more than 40,000 people that showed the shot was 26.6% more effective than a licensed standard-dose flu vaccine. But Dr. Rose says that no saline placebo was used, and the comparator group also received a flu vaccine – and that the data she’s seen indicates high adverse reactions to the new shots.
Dr. Kelly Victory, Chief of Emergency & Disaster Medicine at The Wellness Company, joins Wellness Company CEO Peter Gillooly to discuss RFK’s push to split the childhood MMR vaccine into separate shots, new releases from Dr. Fauci’s pandemic text messages, and TWC’s research on Alpha-Gal.
Dr. Jessica Rose is a Canadian researcher with a Bachelor’s in Applied Mathematics and a Master’s in Immunology from Memorial University of Newfoundland. She holds a PhD in Computational Biology from Bar Ilan University and completed postdoctoral research in Molecular Biology and Biochemistry. Follow at https://jessicasuniverse.com
Dr. Kelly Victory is Chief of Emergency & Disaster Medicine at The Wellness Company and a trauma and emergency specialist with over 30 years of experience. Follow at https://x.com/DrKellyVictory
Peter Gillooly is CEO of The Wellness Company. Through the organization’s initiatives and products, he promotes patient-first care and individual control over health decisions. Learn more at https://drdrew.com/twc
